Major histocompatibility complex class I–restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction C Kurts, JFAP Miller, RM Subramaniam, FR Carbone, WR Heath The Journal of experimental medicine 188 (2), 409-414, 1998 | 428 | 1998 |
Brain PET in the diagnosis of Alzheimer’s disease C Marcus, E Mena, RM Subramaniam Clinical nuclear medicine 39 (10), e413-e426, 2014 | 410 | 2014 |
Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002) SS Yom, P Torres-Saavedra, JJ Caudell, JN Waldron, ML Gillison, P Xia, ... Journal of Clinical Oncology 39 (9), 956-965, 2021 | 259 | 2021 |
18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging EH Dibble, ACL Alvarez, MT Truong, G Mercier, EF Cook, ... Journal of Nuclear Medicine 53 (5), 709-715, 2012 | 251 | 2012 |
Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis RM Subramaniam, C Suarez-Cuervo, RF Wilson, S Turban, A Zhang, ... Annals of internal medicine 164 (6), 406-416, 2016 | 219 | 2016 |
Thyroid–differentiated and anaplastic carcinoma RM Tuttle, LF Morris, BR Haugen, JP Shah, JA Sosa, E Rohren, ... AJCC cancer staging manual, 881-898, 2016 | 204 | 2016 |
FDG-PET/CT and MRI for evaluation of pathologic response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis of diagnostic accuracy studies S Sheikhbahaei, TJ Trahan, J Xiao, M Taghipour, E Mena, RM Connolly, ... The oncologist 21 (8), 931-939, 2016 | 195 | 2016 |
Brain FDG PET and the diagnosis of dementia VKN Shivamurthy, AK Tahari, C Marcus, RM Subramaniam American Journal of Roentgenology 204 (1), W76-W85, 2015 | 195 | 2015 |
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing CH Chung, VB Guthrie, DL Masica, C Tokheim, H Kang, J Richmon, ... Annals of oncology 26 (6), 1216-1223, 2015 | 194 | 2015 |
Head and neck PET/CT: therapy response interpretation criteria (Hopkins criteria)—interreader reliability, accuracy, and survival outcomes C Marcus, A Ciarallo, AK Tahari, E Mena, W Koch, RL Wahl, AP Kiess, ... Journal of nuclear medicine 55 (9), 1411-1416, 2014 | 185 | 2014 |
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland D Karantanis, TV Bogsrud, GA Wiseman, BP Mullan, RM Subramaniam, ... Journal of Nuclear Medicine 48 (6), 896-901, 2007 | 178 | 2007 |
Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT Y Sanli, I Garg, A Kandathil, T Kendi, MJB Zanetti, S Kuyumcu, ... American Journal of Roentgenology 211 (2), 267-277, 2018 | 174 | 2018 |
Role of FDG PET/CT in the eighth edition of TNM staging of non–small cell lung cancer A Kandathil, FU Kay, YM Butt, JW Wachsmann, RM Subramaniam Radiographics 38 (7), 2134-2149, 2018 | 158 | 2018 |
Clinical practice in PET/CT for the management of head and neck squamous cell cancer R Goel, W Moore, B Sumer, S Khan, D Sher, RM Subramaniam American Journal of Roentgenology 209 (2), 289-303, 2017 | 145 | 2017 |
Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis J Eng, RF Wilson, RM Subramaniam, A Zhang, C Suarez-Cuervo, ... Annals of internal medicine 164 (6), 417-424, 2016 | 135 | 2016 |
Fluorodeoxyglucose–positron-emission tomography imaging of head and neck squamous cell cancer RM Subramaniam, M Truong, P Peller, O Sakai, G Mercier American Journal of Neuroradiology 31 (4), 598-604, 2010 | 126 | 2010 |
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma V Paidpally, A Chirindel, S Lam, N Agrawal, H Quon, RM Subramaniam Imaging in medicine 4 (6), 633, 2012 | 124 | 2012 |
Value of PET/CT in the management of primary hepatobiliary tumors, part 2 A Sacks, PJ Peller, DS Surasi, L Chatburn, G Mercier, RM Subramaniam American Journal of Roentgenology 197 (2), W260-W265, 2011 | 120 | 2011 |
Methods and challenges in quantitative imaging biomarker development RG Abramson, KR Burton, JY John-Paul, EM Scalzetti, TE Yankeelov, ... Academic radiology 22 (1), 25-32, 2015 | 117 | 2015 |
The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer S Sheikhbahaei, E Mena, A Yanamadala, S Reddy, LB Solnes, ... American Journal of Roentgenology 208 (2), 420-433, 2017 | 116 | 2017 |